Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China
· Delayed Price · Currency is CNY 16.78
+0.02 (0.12%)
Mar 9, 2026, 3:04 PM CST
SHE:002603 Revenue
Shijiazhuang Yiling Pharmaceutical had revenue of 1.83B CNY in the quarter ending September 30, 2025, with 3.78% growth. This brings the company's revenue in the last twelve months to 6.01B, down -25.83% year-over-year. In the year 2024, Shijiazhuang Yiling Pharmaceutical had annual revenue of 6.51B, down -36.88%.
Revenue (ttm)
6.01B
Revenue Growth
-25.83%
P/S Ratio
4.66
Revenue / Employee
513.74K
Employees
11,708
Market Cap
28.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.51B | -3.81B | -36.88% |
| Dec 31, 2023 | 10.32B | -2.21B | -17.67% |
| Jan 1, 2023 | 12.53B | 2.42B | 23.88% |
| Jan 1, 2022 | 10.12B | 1.33B | 15.19% |
| Dec 31, 2020 | 8.78B | 2.96B | 50.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Livzon Pharmaceutical Group | 11.85B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 5.37B |
| Kangmei Pharmaceutical | 5.28B |
| Chengdu Kanghong Pharmaceutical Group | 4.67B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Humanwell Healthcare (Group) | 24.18B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Dizal (Jiangsu) Pharmaceutical | 801.14M |